Personal information

Activities

Funding (1)

Targeting complement anaphylatoxin C3a receptor to break immunotherapy resistance in colorectal cancer

2024-07-01 to 2028-06-30 | Grant
American Cancer Society (Atlanta, US)
GRANT_NUMBER:

RSG-24-1255025-01-IBCD

Source: check_circle
American Cancer Society - ProposalCentral